Clinical Trial Update: Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Angiomax (bivalirudin) to heparin with protamine in patients undergoing cardiopulmonary bypass has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease

Drugs mentioned

• Angiomax (bivalirudin)
• Heparin (unfractionated heparin)
• Protamine (protamine sulfate)

Snippet

Sponsor: The Medicines Company | Conditions: Cardiovascular Disease, Coronary Artery Bypass Surgery | Phase 3 | Status: COMPLETED